Endometrial Cancer
📧 Sign up to get email alerts when something new happens for Endometrial Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Evaluation of Laparoscopic Staging Versus Staging Laparotomy for Early Stage Endometrial Cancer [NA]
A clinical trial is evaluating laparoscopic staging versus staging laparotomy for early-stage endometrial cancer, with the study status not …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Adaptive Radiotherapy for Safe Hypofractionation [Phase 2]
A Phase 2 clinical trial update describes adaptive radiotherapy to enable safe hypofractionation across several cancers. The study is curren…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer [NA]
This entry highlights a clinical trial evaluating MR-guided adaptive stereotactic radiotherapy for endometrial cancer. The study status is n…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors [Phase 1]
FT836 is being studied in a Phase 1 trial for advanced solid tumors, administered with or without chemotherapy and/or monoclonal antibodies.…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha [Phase 1]
Phase 1 study of MOv18 IgE in solid tumors expressing folate receptor alpha is currently recruiting, evaluating safety and early signals of …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) [Phase 3]
A Phase 3 clinical trial update for Sacituzumab Tirumotecan (MK-2870) in endometrial cancer after platinum therapy and prior immunotherapy; …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Memorial Sloan Kettering Cancer Center is conducting an observational study to track outcomes of women with endometrial cancer receiving sta…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/Phase 2 study evaluating targeted agents for patients with recurrent or persistent endometria…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types [Phase 1]
IDEAYA Biosciences is conducting a Phase 1 study of IDE034 in adults with multiple locally advanced or metastatic solid tumors; the trial is…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) [Phase 1]
A Phase 1 trial to assess tolerability of different doses of BI 3820768 in adults with advanced relapsed or refractory germ cell tumors, end…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Predictive Clinical and Biological Parameters in Gynecological Cancer [NA]
Ongoing study evaluating predictive clinical and biological parameters across gynecologic cancers (ovarian, endometrial, and cervical cancer…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]
This Clinical Trials Update describes a Phase 1 study of an Fc-engineered anti-CTLA-4 monoclonal antibody by Agenus in patients with advance…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors [Phase 1]
Phase 1 trial update on the safety of RAD301 in healthy volunteers and patients with pancreatic ductal adenocarcinoma or other solid tumors;…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study [NA]
This completed clinical trial investigates lifestyle and empowerment techniques in survivorship for gynecologic cancers. The study includes …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer [Phase 3]
Phase 3 clinical trial update evaluating sentinel lymph node mapping in Stage I endometrial cancer and its effect on patient-reported lower-…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 studies of the radiopharmaceutical 177Lu-BetaBart. The trial is evaluating its use in…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating HWK-007, a PTK7-directed antibody-drug conjugate, for advanced solid tumors; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors [Phase 1]
This is a Phase 1 study evaluating CGT6297, a mutant-selective inhibitor, in adults with advanced solid tumors, including PIK3CA-mutant endo…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Avera Cancer Sequencing and Analytics Protocol (ASAP)
This entry outlines the ASAP cancer sequencing and analytics protocol from Avera Cancer, currently recruiting to study sequencing-based canc…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation [NA]
Clinical trial update describing the ENDORISK study, which aims to individualize endometrial cancer risk stratification using a Bayesian pre…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]
A Phase 2 study evaluating Envafolimab alone or in combination with Lenvatinib for advanced endometrial cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of Ivonescimab in People With Endometrial and Cervical Cancers [Phase 2]
Phase 2 clinical trial investigating Ivonescimab in patients with endometrial cancer and cervical cancer, currently recruiting.